Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT05113030

NCT05113030
Completed Not Applicable

Who may be able to join

"Who might be able to join this trial:

  • You must be female and have recently been diagnosed with Polycystic Ovary Syndrome (PCOS) using a specific set of medical guidelines called the Rotterdam criteria.
  • You must be between 11 and 19 years old (adolescent group) or between 20 and 40 years old (adult group).
  • You must have more than 16 natural teeth.

Who may not be able to join:

  • You may not be able to join if you have a history of thyroid problems, high levels of a hormone called prolactin, or tumors that produce male hormones.
  • You may not be able to join if you have a long-term inflammatory illness such as kidney disease, serious heart disease, type 1 or type 2 diabetes, or if you have had cancer in the past 5 years.
  • You may not be able to join if you currently use or have a history of using tobacco or alcohol.
  • You may not be able to join if you have taken antibiotics in the past 3 months.
  • You may not be able to join if you have had any dental or gum treatment in the past 6 months.
  • You may not be able to join if you have been diagnosed with a severe form of gum disease called aggressive periodontitis (confirm with trial site).
  • You may not be able to join if you are currently taking birth control pills, are pregnant, or are breastfeeding.

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Postgraduate Institute of Dental Sciences Rohtak
Registry
clinicaltrials_gov
Start date
1 November 2021
Est. completion
15 June 2022

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Bleeding on probing(BOP),; Probing pocket depth(PPD), in both the groups.; Serum hsCRP levels( high sensitivity C reactive proteins)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov